Categorized | Marijuana Penny Stocks

Top Marijuana Stocks to Buy in 2017

FL-Logo-490px

Bud Stocks that are finest to keep This is our Focus List
On these pages you’ll find a listing of businesses that in our view have long-term possibility. Businesses which have business and technology models that we feel are unique and include possibility for the long-term accomplishment within theMarijuana space. Our Focus List is in our view the “Finest Pot Stocks to keep focused on”. We’ll be updating YOU our subscribers via facebook, twitter, e-mail & text on all developments both negative along with favorable for every business listed on our Focus List.

We’re aware that NO business particularly in this sector is without its share of inspection. Our “Focus List” is predicated on our views as well as our research. BUT, or propose an organization to add and or need to express your views or take away we welcome your feedback and if ANY of YOU find tips, and we DON’T have all of the responses.

*Notice* we’re now hard at work to populate this page with advice and the most effective marijuana stocks potential. It is necessary to say that although we do offer advertisements on this particular site, or “3rd party” and NO company can pay to get their business listed on our focus list. Yet we do reserve the right to release or intends to market on this particular site and a firm which has advertised for all to see, and we’ll disclaim such damages definitely.
________________________________________

AbbVie Inc. (NYSE: ABBV)
AbbVie Inc. discovers, develops, produces, and sells pharmaceutical products worldwide. Their Marinol drug is FDA-approved for treating nausea in patients undergoing chemotherapy and is also prescribed to AIDS patients afflicted by loss of desire. The drug is delivered as an oral capsule and is made from a synthetic kind of THC.
Even though marijuana is still classified by the DEA as a Schedule I drug, Marinol is recorded as a Schedule III drug, meaning the FDA understands the clinical advantages and exploitation potentials are considered to be lower.
The business additionally offers Humira, Imbruvica an oral treatment for treating chronic lymphocytic leukemia a biologic treatment administered as a subcutaneous injection to take care of autoimmune diseases; an interferon, and Viekira Pak -free treatment for adults with genotype 1 chronic hepatitis. Additionally, it supplies Kaletra, an anti-HIV-1 medication used with other anti-HIV-1 drugs as a treatment that keeps viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in conjunction with other antiretroviral agents to take care of HIV-1; and Synagis to prevent respiratory syncytial virus disease in high risk babies. The organization sells its products to independent retailers from its distribution centers and public warehouses, vendors, government agencies, health care facilities, specialty pharmacies, and wholesalers.
The business is located in Vancouver, Canada. Their state of the art facility was created to make the cleanest, safest medical cannabis that can be found in the marketplace.

Cara Therapeutics Inc. (NASDAQ: CARA)
Cara is developing without targeting CNS cannabinoid receptors lead molecules that modulate peripheral CB receptors. Peripheral CB receptor modulators will be created as a new therapeutic strategy for inflammatory and neuropathic pain, a state now without treatments that are consistently successful. Cara’s CR701, most innovative CB compound, is now in preclinical development.
The firm is also developing cannabis-based product candidates that target peripheral nervous system is ’sed by the body. The organization is also developing Oral CR845, which is in Phase IIa clinical trials for treating moderate-to-serious acute and persistent pain.

GW Pharmaceuticals
GW Pharmaceuticals plc is a biopharmaceutical company that, collectively with its subsidiaries, engages in developing, finding, and commercializing prescription medicines that are cannabinoid. It operates through three segments: Pipeline Research, Sativex Research and Development, and Commercial and Development. The firm principally offers Sativex, an oromucosal spray for treating spasticity due to multiple sclerosis. Additionally, it targets the Phase III clinical development system of Sativex for use in Phase 2 trials in other indicators; and treating cancer pain, including neuropathic pain. By 39% in kids with a sort of epilepsy referred to as Dravet syndrome, in comparison with a 13% decrease in kids who took a placebo, the drug reduced the frequency of seizures in a Phase III trial for Epidiolex. It runs in America, Europe, the Uk, Canada, and Asia.

mCig Inc. (OTC: MCIG)
It gives electronic cigarettes and relevant products through its online store mcig.org, in addition to through the business’s wholesale, distributor, and retail plans. The organization also supplies cannabis grower services including general pot business consulting, warehouse customization, greenhouse grows, private residence grow room components, and advertisement grow room layout.

Canopy Growth Corporation (CGC.V) (OTC: TWMJF)
Canopy Growth Corporation, through its subsidiaries, sells and makes medical cannabis in Canada. They manage a group of curated form variety and varied brands, supported by over half a million square feet of indoor greenhouse output capacity. The organization provides petroleum products and dry cannabis principally under the Bedrocan and Tweed brands. In addition, it sells its products online. The organization got Bedrocan Cannabis Corp. in 2015 for about $58 million. Canopy Increase is the greatest manufacturer of health cannabis in Canada.

Vitality Biopharma, Inc. (OTC: VBIO)
Cannabosides – A Fresh Category of Cannabinoid Pharmaceuticals
Site-special delivery could empower oral drug formulas of cannabinoids to supply healing advantages while preventing or reducing the systemic delivery of THC into the bloodstream. Now, high concentrations of psychoactive THC in the brain restrict the dose of cannabinoids which can be utilized elsewhere in the body for treatment of inflammation as well as pain.
Most patients are diagnosed before age 30 and need lifelong treatment.
Prodrugs are usually designed to defeat well known drawbacks of currently available treatments. Energy’s prodrug technology empowers the particular targeting of particular tissues or organs, including brain or the bowel, enabling the drug to get a targeted effect. As of 2015, there were about 15 prodrugs that was classified as hits, defined as having annual revenues in excess of $1 billion.

Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE)
Its product candidates contain Fragile X syndrome ZYN002, which is in Phase I clinical trial for treating refractory epilepsy, and osteoarthritis; and ZYN001 that’s in preclinical stage for treating peripheral neuropathic pain and fibromyalgia
Overview
The state of the cannabis market is attractive for investors than ever before. With unpredictability and the first hoopla out of the way, investors are now able to start looking at firms with market capitalizations that are reasonable or undervalued. With several important drivers coming up, we anticipate as the entire sector grows the companies mentioned on this particular list to advance and do on their business plans.

Nutrafuels Inc. (OTC: NTFU)
Nutrafuels (NASDAQ:NTFU). NutraFuels is a U.S. based nutraceutical manufacturer located in Coconut Creek Florida. The facility has been inspected and approved by the Florida Department of Agriculture, is FDA registered and 3rd Party cGMP certified. Our staff has been trained and is certified under cGMP requirements. NutraFuels products are manufactured under the highest quality standards and industry protocols. Nutrafuels portfolio of companies include industry CBD Leader Hemp Genix, Skin Care Manufacturer leader NF Skin, Oral Pro Nutra Spray, Nutra Pro Shot and others. Nutra Fuels leads the manufacturering industry in unique CBD Oral Spray products and other liquid CBD Products

Canna Securities CSA Holdings Inc. (OTC: CSAX)
Whether or not you should buy a stock depends heavily on the future prospects for that business. Canna Securities (NASDAQ:CSAX) stands out as one marijuana stock that does seem to have solid prospects. The company’s focus is not marijuana itself which makes this a winner.
Canna Security America (CSA) was created in 2009 to meet the growing needs of the evolving medical cannabis industry from a legal, regulatory compliance, and security aspect. CSA was instrumental in the development of Colorado’s legal cannabis market. CSA worked on the rule-making committee in the Department of Revenue and helped to formulate the security regulations for medical marijuana in the state. Currently, CSA is recognized as a leader in security and compliance services for the legal cannabis industry. CSA provides high quality and dependable solutions that are adaptable to meet the constantly changing security and compliance challenges in the industry. CSA offers a full range of high quality services to help clients’ businesses achieve sustainable growth. Thus, CSA is able to assist cannabis entrepreneurs grow and succeed in this young and dynamic market place.
From our inception, CSA has specialized in engineering custom security systems specifically to ensure full compliance with all federal, state, and local laws. We provide effective security solutions to cannabis businesses, including armed and unarmed guards, armored transport, alarms, door access systems, video surveillance, security system design, and state licensing consulting.

Freedom Leaf Inc. (OTC: FRLF)
Freedom Leaf, Inc., The Marijuana Legalization Company, is a fully reporting and audited, publicly traded company. Freedom Leaf, Inc. is the leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. Our Founders and the Freedom Leaf Leaf team has nearly 200 years collective experience in the marijuana legalization effort, which gives Freedom Leaf great credibility as a trusted source in the global Cannabis Hemp sector. Freedom Leaf Inc.’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. The company produces a portfolio of news, print and digital multi-media verticals, websites, and web advertising, for the ever changing emerging cannabis, medical marijuana and industrial hemp industry. In addition, Freedom Leaf also has an operating division: the FLI Agency that is a full service creative, marketing and talent agency servicing clients for the creation and launch of private label products. With full service production capabilities to craft unique brands, affiliate marketing and direct sales programs to service the rapidly growing nutritional supplement and skin care industries. FLI Agency can handle every aspect of the production in addition to branding, licensing and marketing. Freedom Leaf, Inc. does not handle, grow, sell, or disperse marijuana or related products. Therefore, we are not regulated in any way by the different government agencies other than standard business type of regulations.

Our extensive list of services includes armored transport, armed and unarmed guards, comprehensive background checks, and site risk assessments. CSA’s guards dress professionally with the appropriate identification and have a law enforcement or military background. Our new fleet of Mercedes-Benz Sprinter vehicles have been up-armored with the latest bullet-resistant technology, are GPS tracked, and equipped with the a 4-point camera system that transmits live streaming footage to our command center. This guarantees total traceability from pickup to drop-off. CSA can now offer comprehensive security solutions to the cannabis industry that is second to none.
CSA now services over 130 clients in 500 plus facilities in 14 legal marijuana states all achieving and 100% licensing approval rating, and is currently consulting with new clients as regulations continue to change. With an increasing number of states implementing regulated dispensary models, CSA is able to leverage their expertise in complying with different state’s security codes, standards, and guidelines to provide clients with innovated and cost-effective security solutions.
As a national leading security firm, CSA knows where the risk points exists for cannabis businesses, and how to tailor services to ensure maximum loss prevention and legal compliance. We have positioned ourselves as the market leader and brand name in the cannabis security industry.

This business is here to remain and we’ve created this Free User guide to help all interested investors get started!”

Comments are closed.

CSAX
0.06
0.00
0.00%
 
FRLF
0.031
0.00
-1.431%
 
NTFU
0.231
-0.043
-15.786%
 
CSAX
0.06
0.00
0.00%
 
FRLF
0.031
0.00
-1.431%
 
NTFU
0.231
-0.043
-15.786%